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Research Article

Porous Floating Beads of Ornidazole: Formulation and In Vitro
Characterization
Ganesh Hebbar*, Ashwini Rajendra, Anegundha Srinatha
Email: ganeshhebbar1995@gmail.com

Abstract
The aim of the present study was to develop a floating drug delivery system using Ornidazole porous beads with
sodium alginate and cetyl alcohol. Sodium alginate beads containing cetyl alcohol was prepared by ionotropic
gelation technique using calcium chloride solution (5% w/v) as coagulation fluid. The embedded wax was removed
by heating the beads at 50-55°C. The influence of wax amount on drug release and buoyancy was studied. The
prepared beads were evaluated for morphological changes, bead size, encapsulation efficiency, floating properties
and in vitro drug release. Bead sizes ranged from 1.142±0.062 mm to 1.274±0.05 mm. In simulated gastric fluid,
the beads remained afloat for > 24 h. The quantity of wax and curing time of bead did not affect in vitro drug
release.
Key words: Ornidazole, sodium alginate, wax removal, porous floating beads.

Introduction
Administration of drugs orally is a convenient route
for drug delivery due to its advantages such as less
cost, good patient compliance and ease of use. But,
oral drug delivery has several demerits i.e rapid
gastric emptying, reduced bioavailability due to its
low absorption and deterioration in the alimentary
tract 1. Approaches like bioadhesion, low density
system, high density system, expanding system
and modified - shape system may delay the gastric
emptying time 2. One of the novel approaches for
enhancing the gastric retention time in the stomach
is non-effervescent low density system. 1
The polymers like Eudragit®, low methoxylated
pectin, cellulose acetate phthalate, agar and alginic
acid derivatives are used as carries in various floating
approaches3. Instant floating can be achieved by the

low-density system (density < 1 g/cm3), for example
entrapment of the air in the dosage form or by
incorporation of oil or waxes 1. Many methods have
been developed for the low-density floating systems,
solvent evaporation, including a gas forming agent
or making the system porous 2.
In this work an effort is made to formulate the
floating beads containing anti-protozoal drug
(Ornidazole). Ornidazole is an anti- protozoal
drug use to treat some protozoal infection and also
stomach infections 4. It is soluble in ethanol, acetone
and its water solubility is 3.34 mg/ml. Dosage range
from 400-500 mg daily for adults and 125-150 mg
daily for children.

Materials

Ganesh Hebbar, Ashwini Rajendra,
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Ornidazole was received as a gift sample from Micro
Labs Pvt Limited, Bangalore. Sodium alginate
was procured from SD Fine Chem, Mumbai. Cetyl
alcohol was obtained from Alpha Chemika, Mumbai,
Maharashtra. Calcium chloride and acetone were
received from Alpha Chemika, Mumbai.
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Preparation of porous floating beads 1,5:
Wax removal technique was used to prepare porous
floating beads. The polymer was dissolved in
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Table 1: Different batches with formulation variables
Ingredients

F1

F2

F3

F4

F5

F6

F7

F8

F9

F10

Ornidazole (mg)

125

125

125

125

125

125

125

125

125

125

Sodium alginate (%)

1

1

1

1

1

2

2

2

2

2

Cetyl alcohol (mg)

250

500

750

250

250

250

500

750

250

250

Acetone (ml)

2

2

2

2

2

2

2

2

2

2

Curing time (min)

5

5

5

10

15

5

5

5

10

15

of 400-4000 cm-1 using the FTIR spectrometer
distilled water. Then drug, acetone and cetyl alcohol
(Shimadzu 84000S, Japan).
was added polymeric solution as given in Table 1.
Then mixing was done homogenously by using
Differential Scanning Calorimetry (DSC):
magnetic stir. The dispersion containing wax was
Differential scanning calorimeter (DSC-60 Plus,
then extruded through 18 gauges needle into
5% Transform
of
Fourier
InfraredJapan)
(FTIR) was
spectroscopy:
Shimadzu,
used to obtain DSC peaks
calcium chloride solution. The formed beads were
of ofpure
drug and and
the the
prepared
The
DSC by scanning th
The FTIR spectra
pure formulation
final one beads.
(F2) were
obtained
cured by gentle stirring at room temperature and
thermogram
was
obtained
by
sealing
the
drug
or
samples within the range of 400-4000 cm-1 using the FTIR spectrometer (Shimadzu
84000S
filtered. The wax (cetylalcohol) removal was induced
formulation
in
hermetically
in
an
aluminum
pan
by heating the beads at 50-55 °C for aboutJapan).
an hour.
and kept under nitrogen purging (atmosphere). The
Differential Scanning Calorimetry (DSC):

samples were scanned from room temperature to

Differential scanning
calorimeter
Plus, min.
Shimadzu, Japan) was used to obtain DS
300 °C
and with(DSC-60
10 °C rise/
peaks of pure drug and the prepared beads. The DSC thermogram was obtained by sealing th

Size determination of porous floating beads:
The diameter of the 100 beads were determined
(atmosphere). The samples were scanned from room temperature to 300 °C and with 10 °C ris
using calibrated eye piece micrometer by optical
min.
microscopy.

drug or formulation in hermetically in an aluminum pan and kept under nitrogen purgin

Size determination of porous floating beads:

(a)

Morphology of porous floating beads:
electron
microscopyusing
wascalibrated
used in eye
analysis
The diameter ofScanning
the 100 beads
were determined
piece micrometer by
of the surface and internal structure of the floating
optical microscopy.
beads. The prepared beads were subjected to sputter
wherebeads:
ultra-thin coating of electrically
Morphology of coating
porous floating
conductive
such
gold of
is the
applied
onto
bead. structure of the
Scanning electron
microscopymetal
was used
in as
analysis
surface
and ainternal
Next, scanning electron microscope (JSM 6380LA,
floating beads. The prepared beads were subjected to sputter coating where ultra-thin coating
Joel India) was used to observe the sputter coated
of electrically conductive metal such as gold is applied onto a bead. Next, scanning electron
beads.
microscope (JSM 6380LA, Joel India) was used to observe the sputter coated beads.

Drug content and encapsulation efficiency:
It was determined by crushing the beads in a
glass
mortartheand
pestle
andmortar
shaking
the crushed
It was determined
by crushing
beads
in a glass
and pestle
and shaking the crushed
beads with 100 ml of 0.1N HCl for 48 hours. After
beads with 100 ml of 0.1N HCl for 48 hours. After crushing, filtration was done using Whatman
crushing, filtration was done using Whatman filter
filter paper and suitably diluted. It was then analysed using UV spectrophotometer (1601
paper and suitably diluted. It was then analysed
Shimadzu, Japan)
using suitable
blank at 277 nm.
using
UV spectrophotometer
(1601, Shimadzu,
Japan) using suitable blank at 277 nm.
Drug content and encapsulation efficiency:

(b)

Figure 1: FTIR images of (a) pure drug and (b) formulation

Fourier Transform Infrared (FTIR) spectroscopy:
The FTIR spectra of pure and the final one (F2) were
obtained by scanning the samples within the range
16
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Encapsulation efficiency=

Acutacl drug content

Theoritical drug content

∗ 100

The studies were performed in triplicate and results
are given as mean ± SD.

The studies were performed in triplicate and results are given as mean ± SD.
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Table 2: Physico-chemical parameters of the prepared formulations
Formulation code

Diameter ±SD (in mm)

Drug content (mg)

% Encapsulation efficiency

F1

1.252±0.09

88.892±0.06

71.11±0.01

F2

1.220±0.061

97.821±0.08

78.25±0.03

F3

1.274±0.05

94.964±0.026

75.97±0.07

F4

1.251±0.047

82.125±0.04

65.70±0.09

F5

1.266±0.35

59.982±0.02

47.98±0.15

F6

1.208±0.065

73.535±0.05

58.82±0.17

F7

1.225±0.073

67.107±0.14

53.68±0.27

F8

1.224±0.095

69.607±0.19

55.68±0.20

F9

1.142±0.062

61.767±0.11

49.41±0.11

F10

1.227±0.074

54.607±0.05

43.68±0.21

All the prepared batches of beads were buoyant instantaneously and remained buoyant for over 24 hours in the test medium.

Floating properties of the beads 6:
Paddle type USP dissolution apparatus II was
employed to assess the floating capacity and lag time
of the prepared beads. Twenty beads were kept in
the vessel and the paddle was rotated at a speed of
50 rpm in 900 mL of 0.1 N HCl. The floating ability
was measured by visual observation.

(a)

In vitro dissolution studies 7:
It was studied by paddle type USP dissolution
apparatus II. Floating beads were kept in vessels
as previously. The temperature of the media was
maintained at 37±0.5°C and paddle was rotated at
50 rpm. At specific time intervals, the sample was
withdrawn (5 ml) and replaced with the fresh media.
The sample was filtered with 0.45 um membrane
filter. The amount of the Ornidazole in each sample
was estimated by using UV-Spectrophotometer (UV1601, Shimadzu, Japan) at 277 nm. The samples were
analyzed triplicate and the mean (±S.D) reading was
taken.
Drug release kinetic 8:
Various models were used to understand the kinetics
and drug release mechanism by analyzing the in
vitro release data. The experimental data was fitted
to different kinetic models of drug release.

Results and Discusiion

(b)
Figure 2: DSC thermograms of (a) pure drug and (b) formulation

Fourier Transform Infrared spectroscopy (FTIR):
The FTIR spectra of Ornidazole and final
formulation are displayed in the Figure 1. Figure
1(a) exhibits the characteristic peak at 3313 cm-1,
2955cm-1, 1267cm-1, 1147 and 1103 cm-1 as a result
of stretching vibration of the O-H, C-H stretching
for CH3 (methyl), C-O (Carbonyl) and C-N (cyanide)
groups respectively. Peaks also appeared at 1473 cm-1
and 1427 cm-1 due to the deformation of C-H and
O-H of the pure drug sample. Figure 1 (b) showed
the characteristic peaks at 3325 cm-1, 2926 cm-1, 1267
cm-1, 1147 cm-1 and 1105 cm-1 due to the stretching
vibration of the O-H, C-H stretching for CH3, C-O,
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C-N respectively. Peaks were also visible at 1471
cm-1 and 1425 cm-1 because of deformation of C-H
and O-H for final formulation. This confirms that no
interaction between the used drug and polymer was
present.

with onset and endset temperatures of 74.86 °C
and 91.49 °C, respectively. The latent heat of fusion
(ΔHfus) was found to be -527.11 J/g. There was no
considerable change in the melting endotherm of
final formulation compared to that of pure drug
sample. This confirms that no interaction between
the used drug and polymer was present.

Figure 3: In vitro drug release profiles of Ornidazole of
formulations F1 to F5

Differential Scanning Calorimetric Analysis
The obtained Differential Scanning Calorimetric
(DSC) thermograms of Ornidazole and final
formulation are shown in Figure 2. It showed
an endothermic peak at 99.06°C with onset and
endset temperatures of 89.98°C and 105.99 °C
respectively. The latent heat of fusion (ΔHfus)
was found to be -1.23 J/g, indicating crystallinity
of the drug. Similarly, the final formulation DSC
thermogram showed endothermic peak at 83.26°C

Figure 4: In vitro drug release profiles of Ornidazole of
formulations F6 to F10

Particle size analysis
The mean surface diameter of 10 formulations is
showed in Table 2.
Encapsulation efficiency and drug content:
The calculated drug content and the encapsulation
efficiency are showed in Table 2. Drug content in

Figure 5: Scanning Electron Microscopy images of final formulation.
18
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the beads ranged from 54.60 ± 0.05 mg to 97.82
± 0.08 mg and entrapment efficiency was found
between 43.68 ± 0.21% to 78.25 ± 0.03%. F2 and
F3 formulations showed maximum amount of drug
content 97.821 ± 0.08 mg and 94.964 ± 0.026 mg
and drug encapsulation efficiency 78.25 ± 0.03%
and 75.97 ± 0.07% respectively. The amount of the
wax used did not influence the drug content and
entrapment efficiency. Ornidazole is an aqueous
soluble drug and during the preparation it may
be diffused from the beads that reduced the drug
content and entrapment efficiency. The curing time
played an important role in the drug entrapment
efficiency, increased curing time reduced the drug
content and entrapment efficiency this is may be
because of aqueous solubility of the drug.
Floating properties of the beads
The beads instantly floated in 0.1N HCl and remained
in the floating state for 24 hours. Incorporation of
the various amount of the wax did not significantly
influence floating behaviour. The floating behaviours
of the alginate beads may be due to the porous
structure created during wax removal.
In vitro drug release study
0.1 N HCl used to carry out in vitro drug release
studies mimicked the gastric environment and it
was helpful in understanding the applicability of
the beads as gastro-retentive low-density system for
drug delivery. Different amount of waxes were used
in in vitro drug release studies as shown in figure
3 and 4. Initially there was burst release which is
probably due to the tendency of drug to move to
the bead surface during the preparation or drying
period. The drug release also enhanced due to
removal of the wax from the beads. Drug release of
all the prepared formulation ranged from 52.89 ±
3.01% to 74.02 ± 1.49% at 8 hours. The formulations
F2 and F3 showed 73.73 ± 2.11% and 74.02 ± 1.49%
drug release respectively. Formulation F8 showed
low drug release about 52.89 ± 3.01%, because of
polymer used in higher concentration (2%).
In vitro kinetic studies
Various kinetic models were used to fit the drug
release data like Higuch diffusion, zero order, first
order and Korsmeyer–Peppas release models. R2
value was used to define accuracy of all kinetic
models. Formulations F2, F5 and F8 followed the

first order drug release kinetics. Formulations
F6, F7, F9 and F10 followed Higuchi’s model of
diffusion and Formulation F1 followed zero order
drug release kinetics. Kosemeyer-Peppas model
is used to analyze drug release mechanism from
the beads. If the release exponent (n value) is
less than 0.45 it indicates Fickian model, n value
between 0.45 to 0.89 indicates anomalous or nonFickian diffusion, and if n values is more than 0.89
it indicate super case II drug release mechanism.
Formulations F1, F2, F3, F4, F5 and F8 followed
non-Fickian diffusion and formulations F6, F7, F9
and F10 followed Fickian diffusion as n value was
found to be 0.644, 0.737, 0.778, 0.533, 0.456, 0.510
and 0.384, 0.054, 0.354 and 0.395 respectively. From
the evaluation data, it was concluded that porous
beads with desired buoyancy can be developed by
wax removal technique with selective modification
of formulation variables.
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